Ilsung Is Co., Ltd. (KRX:003120)
20,800
-700 (-3.26%)
At close: Jun 5, 2025, 3:30 PM KST
Ilsung Is Revenue
Ilsung Is had revenue of 16.62B KRW in the quarter ending March 31, 2025, with 3.97% growth. This brings the company's revenue in the last twelve months to 69.65B, down -8.48% year-over-year. In the year 2024, Ilsung Is had annual revenue of 69.02B, down -11.58%.
Revenue (ttm)
69.65B
Revenue Growth
-8.48%
P/S Ratio
2.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
144.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 69.02B | -9.03B | -11.58% |
Dec 31, 2023 | 78.05B | 16.81B | 27.44% |
Dec 31, 2022 | 61.25B | 19.16B | 45.52% |
Dec 31, 2021 | 42.09B | 1.49B | 3.67% |
Dec 31, 2020 | 40.60B | -7.81B | -16.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |